疾病筛查诊断解决方案

Search documents
港股异动丨MIRXES飙升35%,再创上市新高
Ge Long Hui· 2025-09-16 02:01
该股自5月23日上市至今,不到4个月时间,股价(较IPO价格23.3港元)已累涨220%。 Mirxes是一家总部位于新加坡的微小核糖核酸(miRNA)技术公司,致力于使疾病筛查诊断解决方案在亚 洲关键市场触手可及。 恒生指数公司此前公告,Mirxes(觅瑞)获纳入恒生综合指数,相关变动已于9月8日起生效,该公司也已 正式成为港股通标的。 延续昨日强势,MIRXES-B(2629.HK)今日盘中再度飙升,一度涨超35%,报75港元,股价再创上市新 高,市值突破200亿港元。 ...
宁德时代启动港股招股;诺力股份拟分拆中鼎智能上市
Mei Ri Jing Ji Xin Wen· 2025-05-12 22:32
Group 1 - CATL (宁德时代) has launched its Hong Kong IPO, offering 118 million H-shares at a maximum price of HKD 263 per share, aiming to raise approximately HKD 31 billion [1] - The IPO is expected to enhance CATL's financing channels, given its position as a leading lithium battery manufacturer [1] Group 2 - Zhixing Technology (知行科技) plans to acquire a majority stake in Suzhou Xiaogongjian Robot Co., a national high-tech enterprise specializing in smart integrated joints and customized robotic arms [2] - This acquisition is anticipated to accelerate Zhixing Technology's technological accumulation and business expansion in the robotics sector, potentially creating new growth opportunities [2] Group 3 - Yuefeng Environmental Protection (粤丰环保) has received approval for its privatization proposal, which will allow the company to operate more flexibly without short-term market pressures [3] - The company will suspend share transfer registration starting May 21, 2025, to ensure the determination of eligible shareholder rights [3] Group 4 - Noli Shares (诺力股份) has submitted an IPO application for its subsidiary, Zhongding Intelligent, to be listed on the Hong Kong Stock Exchange [4] - The IPO is subject to various conditions, including approvals from regulatory bodies, and if successful, it could provide new funding and growth opportunities for Noli Shares [4] Group 5 - Mi Rui Group (觅瑞集团) has passed the listing hearing at the Hong Kong Stock Exchange, focusing on RNA technology for disease screening and diagnostic solutions [5] - The company reported revenues of approximately USD 17.76 million, USD 24.19 million, and USD 20.28 million for 2022, 2023, and 2024, respectively, with increasing losses attributed to R&D and market expansion [5] - With the growing demand for precision medicine, Mi Rui Group is positioned to achieve a turnaround in profitability, potentially delivering long-term value to investors [5] Group 6 - The Hang Seng Index closed at 23,549.46, up 2.98% on May 12, 2023, while the Hang Seng Tech Index rose by 5.16% to 5,447.35, and the National Enterprises Index increased by 3.01% to 8,559.23 [6]